Owens & Minor, Inc.'s aggressive dealmaking and substantial debt have led to a mixed track record and declining stock performance, raising skepticism about future prospects. The company's acquisition of Apria and planned acquisition of Rotech shifted the business towards higher-margin activities, but leverage remains very high. The potential sale of the Products & Healthcare Services segment co...
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today announced important milestones in advancing the medical distribution capabilities of its Products & Healthcare Services (P&HS) business segment, which provides essential products and services to thousands of healthcare customers. These milestones are the result of recent company investments in new technology, automation and a...
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE:OMI) (the “Company”) announced today the upsize and pricing of its private offering (the “Offering”) of $1 billion aggregate principal amount of its 10.000% senior secured notes due 2030 (the “Notes”). The Offering is expected to close on April 4, 2025, subject to customary closing conditions. The Notes will bear interest at the rate of ...
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE:OMI) (the “Company”) announced today that it has launched a private offering (the “Offering”) of $600 million aggregate principal amount of senior secured notes due 2030 (the “Notes”), subject to customary and market conditions. Unless the previously announced acquisition (the “Acquisition”) of Rotech Healthcare Holdings Inc. (“Rotech”) ...
Owens & Minor, Inc. (NYSE:OMI ) Q4 2024 - Earnings Conference Call February 28, 2025 8:30 AM ET Company Participants Jackie Marcus – IR Edward Pesicka - President and CEO Jonathan Leon - CFO Conference Call Participants Kevin Caliendo - UBS Michael Cherny - Leerink Partners John Stansel - JP Morgan Daniel Grosslight - Citigroup Eric Coldwell - Baird Allen Lutz - Bank of America Operator Good da...
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the fourth quarter and year ended December 31, 2024. “We are pleased with the progress that we have made against the strategy as outlined at our Investor Day in December 2023. As a reminder, we committed to optimizing our Products & Healthcare Services business, leveraging our leading Patient Di...
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) (the “Company”) today announced selected preliminary financial results for the fourth quarter and year ended December 31, 2024 in advance of its upcoming earnings announcement and conference call. The release of the preliminary results relates to the Company's commencement of financing activity related to its previously announced a...
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.